Arkolith/Insider Trading/PAHC/Form 4

Bendheim Jack

President and CEO, Director, 10% OwnerPHIBRO ANIMAL HEALTH CORP (PAHC) · full profile →Form 4 · filed Feb 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$545K
Net Open-Market Flow
-$545K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Sell(S)4K$41.15$145K49K
Feb 4, 2026Conversion(C)30K—$052K
Feb 3, 2026Sell(S)7K$41.25$276K25K
Feb 3, 2026Sell(S)3K$41.97$125K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2026Conversion(C)30K—$019.9M

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML